Scarica l'app Stockscreener
10.28
0.10%
0.010
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$10.27
Aprire:
$10.18
Volume 24 ore:
1.09M
Relative Volume:
0.63
Capitalizzazione di mercato:
$744.02M
Reddito:
-
Utile/perdita netta:
$84.01M
Rapporto P/E:
12.01
EPS:
0.856
Flusso di cassa netto:
$-101.16M
1 W Prestazione:
+10.78%
1M Prestazione:
+0.78%
6M Prestazione:
-17.69%
1 anno Prestazione:
+197.11%
Intervallo 1D:
$9.94
$10.35
Intervallo di 1 settimana:
$9.25
$10.69
Portata 52W:
$3.34
$17.65
Omeros Corp Stock (OMER) Company Profile
Nome
Omeros Corp
Settore
Industria
Telefono
206-676-5000
Indirizzo
201 ELLIOTT AVENUE WEST, SEATTLE, WA
Compare OMER vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OMER
Omeros Corp
|
10.28 | 744.02M | 0 | 84.01M | -101.16M | 0.856 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Omeros Corp Stock (OMER) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-10 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-23 | Iniziato | D. Boral Capital | Buy |
| 2024-11-14 | Iniziato | Rodman & Renshaw | Buy |
| 2022-12-08 | Downgrade | UBS | Buy → Neutral |
| 2022-11-08 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-06-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2021-10-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-10-01 | Downgrade | Maxim Group | Buy → Hold |
| 2021-10-01 | Downgrade | Wedbush | Neutral → Underperform |
| 2021-09-27 | Iniziato | JP Morgan | Neutral |
| 2021-02-01 | Iniziato | UBS | Buy |
| 2020-10-20 | Iniziato | BofA Securities | Buy |
| 2020-08-21 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-14 | Reiterato | Maxim Group | Buy |
| 2019-05-06 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-07-12 | Iniziato | Seaport Global Securities | Buy |
| 2018-03-23 | Downgrade | Wedbush | Outperform → Neutral |
| 2018-03-05 | Downgrade | Needham | Buy → Hold |
| 2017-11-08 | Iniziato | H.C. Wainwright | Buy |
| 2017-05-11 | Downgrade | Cantor Fitzgerald | Buy → Neutral |
| 2017-03-17 | Reiterato | Maxim Group | Buy |
| 2017-03-17 | Reiterato | Needham | Buy |
| 2016-11-16 | Reiterato | Wedbush | Outperform |
| 2016-11-10 | Reiterato | Needham | Buy |
| 2016-08-10 | Reiterato | Maxim Group | Buy |
| 2016-06-03 | Iniziato | Cantor Fitzgerald | Buy |
| 2016-03-02 | Reiterato | Needham | Buy |
| 2016-02-29 | Reiterato | Wedbush | Outperform |
| 2015-11-11 | Reiterato | Needham | Buy |
| 2015-08-18 | Reiterato | WBB Securities | Strong Buy |
| 2015-08-10 | Iniziato | ROTH Capital | Buy |
Mostra tutto
Omeros Corp Borsa (OMER) Ultime notizie
OMER Stock On Track For Best Week In Nearly 4 Months After Receiving Permanent Reimbursement Code For Treatment - Stocktwits
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026? - AOL.com
Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026? - The Motley Fool
Omeros shares drop 19% after EMA rejects narsop... - Pluang
OMER Stock Surges 5% After Hours On Novo Nordisk Deal Windfall And Drug Launch Optimism - Stocktwits
Omeros: Yartemlea Faces Headwinds While We Wait On Pipeline Developments - Seeking Alpha
Is Omeros Corporation (OMER) the Best Get Rich Quick Stock to Buy Right Now? - Insider Monkey
Omeros Corporation Files SEC Form 8-K for Other Events – Nasdaq: OMER, July 2026 - Minichart
Omeros to repurchase $16M of 9.50% notes, may buy up to $14.5M more - TradingView
Omeros (NASDAQ: OMER) expands 2029 note repurchases and weighs new debt - Stock Titan
5 Best Get Rich Quick Stocks to Buy Right Now - Insider Monkey
Omeros Corporation Reports First Quarter 2026 Financial Results - The National Law Review
Omeros stock drops 19% after EU rejects key dru... - Pluang
OMEROS CORP (OMER) Stock Chart - ChartMill
Omeros stock crashes on regulatory setback: Buy the dip? - MSN
Biohaven, Goodyear Tire And Other Big Stocks Moving Lower In Monday’s Pre-Market Session - Benzinga
FDA Approved, Europe Unconvinced: Omeros' Stem Cell Transplant Treatment Hits Regulatory Divide - Sahm
Crude Oil Falls 4%; US Consumer Sentiment Rises In June - Sahm
Intellia Therapeutics vs. Omeros: Which Emerging Biotech Stock Is a Better Buy in 2026? - AOL.com
Omeros Corp (OMER) Institutional Confidence - TradingKey
Omeros Corp (OMER) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Omeros Corp (OMER) Valuation: PE, PB & Fair Value Analysis - TradingKey
Omeros (OMER) Faces Regulatory Setback for Narsoplimab Approval - GuruFocus
Omeros stock crashes on regulatory setback: buy the dip? - Invezz
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
OMER Maintained by HC Wainwright & Co. -- Price Target Lowered t - GuruFocus
Why is Omeros stock tumbling today? - Investing.com
Omeros' Stem Cell Transplant Treatment Hits Regulatory DivideOmeros (NASDAQ:OMER) - Benzinga
European regulator issues negative opinion on Omeros’ TA-TMA drug - Investing.com
Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA - BioSpace
Omeros (OMER) Shares Drop 25% Following EMA Panel's Negative Opi - GuruFocus
Omeros stock tumbles after EMA panel rejects narsoplimab application - Investing.com
Why Is OMER Stock Falling Today? - Yahoo Finance
Omeros EU review turns negative on rare transplant complication drug - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session - Benzinga
Omeros stock tumbles after EU panel rejects Yartemlea - Investing.com
Omeros stock tumbles after EU panel rejects Yartemlea By Investing.com - Investing.com UK
OMER Forecast — Price Target — Prediction for 2027 - TradingView
[8-K] OMEROS CORP Reports Material Event - Stock Titan
NovoCure vs. Omeros: Which Emerging Pharmaceutical Stock Is a Better Buy in 2026? - AOL.com
Form 4 Omeros Corporation For: 22 June By Investing.com - Investing.com Australia
Omeros Corp Azioni (OMER) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Omeros Corp Azioni (OMER) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Cable Thomas J. | Director |
May 22 '26 |
Sale |
11.61 |
7,500 |
87,039 |
35,067 |
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):